Use a person centered shared decision making approach to guide choice of pharmacologic agents Consider effects on CV and renal comorbidities effectiveness hypoglycemia risk impact on wt cost and access risk for adverse reactions and tolerability and indiv

Use a person-centered shared decision-making approach to guide choice of pharmacologic agents. Consider effects on CV and renal comorbidities; effectiveness; hypoglycemia risk; impact on wt, cost, and access; risk for adverse reactions and tolerability; and individual preferences. [E]